Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …

Artificial intelligence has the potential to revolutionize modern society in all its aspects.
Encouraged by the variety and vast amount of data that can be gathered from patients (eg …

Background & Aims Liver biopsies are a critical component of pivotal studies in non-
alcoholic steatohepatitis (NASH), constituting inclusion criteria, risk stratification factors and …

Clinical routine in hepatology involves the diagnosis and treatment of a wide spectrum of
metabolic, infectious, autoimmune and neoplastic diseases. Clinicians integrate qualitative …

Background and Aims Manual histological assessment is currently the accepted standard for
diagnosing and monitoring disease progression in NASH, but is limited by variability in …

Modern medical care produces large volumes of multimodal patient data, which many
clinicians struggle to process and synthesize into actionable knowledge. In recent years …

The development of artificial intelligence (AI) has increased dramatically in the last 20 years,
with clinical applications progressively being explored for most of the medical specialties …

Background & Aims Liver fibrosis is a key prognostic determinant for clinical outcomes in
non-alcoholic steatohepatitis (NASH). Current scoring systems have limitations, especially in …

BACKGROUND Liver disease indicates any pathology that can harm or destroy the liver or
prevent it from normal functioning. The global community has recently witnessed an …

Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive type of cancer with
an overall survival rate of less than 7-8%, emphasizing the need for novel effective …